A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophyNathalie Goemans, Yasuhiro Takeshima, Zhengning Lin et al.|Neuromuscular Disorders|2017Cited by 128
Correlation of GAA Genotype and Acid-α-Glucosidase Enzyme Activity in Hungarian Patients with Pompe DiseaseAnikó Gál, Mária Judit Molnár, Zoltán Grosz et al.|Life|2021Cited by 5
Clinical manifestation, disease course and response to enzyme replacement therapy in Hungarian patients with Pompe’s diseaseBenjámin Bereznai, Mária Judit Molnár, Anita Trauninger et al.|Orvosi Hetilap|2011Cited by 0
Pompe-kór fenotípusvariációi, kórlefolyása és az enzimpótló kezelés eredményei: hazai tapasztalatok = Clinical manifestation, disease course and response to enzyme replacement therapy in Hungarian patients with Pompe’s diseaseBenjámin Bereznai, Mária Judit Molnár, Anita Trauninger et al.|Repository of the Academy's Library (Library of the Hungarian Academy of Sciences)|2011Cited by 0